PHAR: Pharming Group N.V. O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Pharming Group N.V. diversifikatsiyalashgan sovuq zanjir logistikasiga tayanadi, bu esa biologik mahsulotlarning butunligini va barqaror marjalarni ta'minlaydi. Biznes kengayish sur'atlariga nisbatan P/E koeffitsiyenti bozor qiymatini o'sish dinamikasi bilan vizuallashtiradi, bunda 0.23 qiymati ushbu metrikaning muvozanatini aks ettiradi. Noyob kasalliklar sektorida brendga bo'lgan shifokorlarning yuqori ishonchi Ruconest uchun patent himoyasi bilan to'ldirilgan bo'lib, bu generiklarning tezkor kirib kelishini istisno qiladi.
Pharming Group N.V. (PHAR) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Pharming Group N.V.|PHAR - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi pharming.com|PHAR - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Pharming|PHAR - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Pharming Group|Oraliq qoplash koeffitsiyenti pharming.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
PHAR - Sof foyda|Prognoz qilingan kelajakdagi foyda Pharming Group N.V.|PHAR - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Pharming Corp|PHAR - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Pharming|PHAR - EBITDA operatsion foydasi|So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda Pharming Group|PHAR - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi pharming.com|PHAR - Joriy yilda foyda o'sishi|Keyingi yil uchun bitta aksiya uchun sof foyda o'sishi prognozi Pharming Group N.V.
Kompaniyaning umumiy tahlili:PHAR - Pharming Group NV
PEG koeffitsiyenti P/E koeffitsiyentini sof foyda o'sish sur'atlari bilan solishtiradi, bu esa investorlarga biznes dinamikasi uchun haddan tashqari ko'p to'layotganliklarini aniqlash imkonini beradi. P/E koeffitsiyentining o'sish sur'atlari bilan muvofiqligini tahlil qilish orqali, Pharming Group N.V. (PHAR) kompaniyasining noyob patologiyalar terapiyasi uchun mo'ljallangan patentlangan biofarmatsevtika dori vositalarining savdo kengayishini hisobga olgan holda, uning adolatli qiymatini baholash mumkin.
Pharming Group N.V. raqobatchilari
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|ABCL: PEG multiplikatori|tourmalinebio.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PGEN (Precigen) - PEG multiplikatori|PEG multiplikatori Nektar Therapeutics Inc|Narxning foydaga va o‘sish sur’atiga nisbati Upstream Bio Corp (UPB)|ZBIO (Zenas Corp) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Immunome, Inc. IMNM|GOSS - Narx-foyda va o‘sish multiplikatori|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Septerna, Inc. SEPN|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti SVRA|RIGL (Rigel Pharmaceuticals) - PEG multiplikatori|ANAB - Narxning sof foyda o‘sishiga nisbati|Narx-foyda va o‘sish multiplikatori ATXS (Astria Therapeutics, Inc.)|ENGN (enGene Holdings Inc) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|Narxning sof foyda o‘sishiga nisbati Aerovate Therapeutics, Inc.|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KYTX (kyvernatx.com)|Tiziana Life Sciences Ltd (TLSA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda Cabaletta Bio Inc. (CABA)|Narx-foyda va o‘sish multiplikatori VTYX|PEG multiplikatori Theratechnologies, Inc|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|ELDN: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Agenus Inc. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti CLYM|ZURA - Narxning foydaga va o‘sish sur’atiga nisbati|ATYR (aTyr Pharmaceuticals) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ADAG (adagene.com) - Narx-foyda va o‘sish multiplikatori|IMA - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori STTK|Narxning foydaga va o‘sish sur’atiga nisbati EQ|Narx-foyda va o‘sish multiplikatori CNTB (Connect Biopharma)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati immunic-therapeutics.com|Narxning foydaga va o‘sish sur’atiga nisbati Atara Bio ATRA|IFRX (InflaRx NV) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|X4 Pharmaceuticals, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACET (Adicet Bio)|CELU: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|KZR: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|EDSA - PEG multiplikatori|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|PEG multiplikatori HCWB|PEG multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ADTX|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori revbiosciences.com|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Narx-foyda va o‘sish multiplikatori Scinai Immunotherapeutics Ltd (SCNI)|Narx-foyda va o‘sish multiplikatori CALI (CalciMedica, Inc.)|PEG multiplikatori affimed.com (AFMD)|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|IGM Bio - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda iTeos Therapeutics Inc|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati TCBP (TC BioPharm Ltd)|THRD (Third Harmonic Bio) - PEG multiplikatori
